FRANK CALDERONI - 10 Dec 2021 Form 4 Insider Report for Anaplan, Inc. (PLAN)

Signature
/s/ Gary Spiegel, Attorney-in-Fact
Issuer symbol
PLAN
Transactions as of
10 Dec 2021
Net transactions value
-$3,066,054
Form type
4
Filing time
14 Dec 2021, 20:13:38 UTC
Previous filing
12 Nov 2021
Next filing
12 Jan 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PLAN Common Stock Sale $1,035,519 -22,396 -4% $46.24 539,063 10 Dec 2021 By Trust F1, F2, F3
transaction PLAN Common Stock Sale $357,864 -7,604 -1.4% $47.06 531,459 10 Dec 2021 By Trust F1, F3, F4
transaction PLAN Common Stock Options Exercise +51,113 +7.5% 728,848 10 Dec 2021 Direct F5
transaction PLAN Common Stock Sale $1,162,194 -25,681 -3.5% $45.26 703,167 13 Dec 2021 Direct F6
transaction PLAN Common Stock Options Exercise +9,760 +1.4% 712,927 10 Dec 2021 Direct F7
transaction PLAN Common Stock Sale $221,931 -4,904 -0.69% $45.26 708,023 13 Dec 2021 Direct F6
transaction PLAN Common Stock Options Exercise +8,361 +1.2% 716,384 10 Dec 2021 Direct F8
transaction PLAN Common Stock Sale $190,116 -4,201 -0.59% $45.26 712,183 13 Dec 2021 Direct F6
transaction PLAN Common Stock Options Exercise +4,327 +0.61% 716,510 10 Dec 2021 Direct F9
transaction PLAN Common Stock Sale $98,430 -2,175 -0.3% $45.26 714,335 13 Dec 2021 Direct F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PLAN Restricted Stock Units Options Exercise $0 -51,113 -25% $0.000000 153,337 10 Dec 2021 Common Stock 51,113 Direct F5
transaction PLAN Restricted Stock Units Options Exercise $0 -9,760 -14% $0.000000 58,557 10 Dec 2021 Common Stock 9,760 Direct F7
transaction PLAN Restricted Stock Units Options Exercise $0 -8,361 -10% $0.000000 75,254 10 Dec 2021 Common Stock 8,361 Direct F8
transaction PLAN Restricted Stock Units Options Exercise $0 -4,327 -7.1% $0.000000 56,253 10 Dec 2021 Common Stock 4,327 Direct F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $45.77 to $46.76, inclusive. The Reporting Person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4.
F3 The shares are held by the Frank Calderoni & Brenda Zawatski Living Trust U/A/D 3/11/05, of which the Reporting Person and his wife are trustees and beneficiaries.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $46.77 to $47.38, inclusive. The Reporting Person undertakes to provide to the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range(s) set forth in this footnote of this Form 4.
F5 The Reporting Person was granted restricted stock units ("RSUs") which represent a contingent right to receive one share of Common Stock for each RSU. 50% of the RSUs vested on September 10, 2020, with the remainder vesting in equal quarterly installments thereafter provided that the Reporting Person remains in continuous service on each vesting date. Unless otherwise provided, on each vesting date shares of Common Stock will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction.
F6 The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F7 The Reporting Person was granted restricted stock units ("RSUs") which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs vest quarterly over 4 years with the first vest date on September 10, 2019, provided that the Reporting Person remains in continuous service on each vesting date. Unless otherwise provided, on each vesting date shares of Common Stock will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction.
F8 The Reporting Person was granted restricted stock units ("RSUs") which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs vest quarterly over 4 years with the first vest date on June 10, 2020, provided that the Reporting Person remains in continuous service on each vesting date. Unless otherwise provided, on each vesting date shares of Common Stock will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction.
F9 The Reporting Person was granted restricted stock units ("RSUs") which represent a contingent right to receive one share of Common Stock foreach RSU. The RSUs vest quarterly over 4 years with the first vest date on June 10, 2021, provided that the Reporting Person remains incontinuous service on each vesting date. Unless otherwise provided, on each vesting date shares of Common Stock will automatically be sold tosatisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction.